Table 2.
Cardiac T2* (ms) | Clinical implication |
---|---|
≥20 | No significant cardiac iron loading; continue current chelation |
10 to <20 | Mild to moderate cardiac iron loading with increased risk of cardiac complications; consider intensification of chelation such as increased dosea and/or continuous infusion (for deferoxamine); combination therapy with deferiprone and deferoxamine if available |
<10 | Severe cardiac iron loading with high risk of cardiac complications; intensify chelation such as increased dosea and/or continuous infusion (for deferoxamine); combination therapy with deferiprone and deferoxamine if available |
Note:
Chelator dose should not exceed approved range (see Table 3).